Yubo International Biotech YBGJ Ratios (2010-2026)

OTC YBGJ
$0.01 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT
Reported Financials

Yubo International Biotech Quarterly Ratios

Periods 52 quarters
Latest Mar 2026

Yubo International Biotech ratios data for the quarter ended Mar 2026. These financial ratios cover 52 quarters of results from Nov 2010 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Nov2010 Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin
74.46%65.87%54.34%73.41%65.84%43.50%36.84%61.89%80.30%81.05%76.29%66.10%
EBT Margin
-351.99%-116.83%-3,805.61%-6,167.62%-1,633.03%155.76%-202.19%-25,687.20%1.47%-2,321.56%-11,740.40%-2,312.40%
EBIT Margin
-351.99%-116.83%-3,805.53%-6,166.88%-1,634.22%155.57%-202.11%-25,683.64%1.50%-2,321.28%-11,737.99%-2,310.92%
EBITDA Margin
-346.85%-115.08%-3,768.86%-6,100.58%-1,598.04%172.70%-196.00%-24,402.38%12.48%-1,804.98%-10,403.76%-1,951.34%
Operating Margin
-351.99%-116.83%-3,805.53%-6,166.88%-1,634.22%155.57%-202.11%-25,683.64%1.50%-2,321.28%-11,737.99%-2,310.92%
Net Margin
-342.39%-119.53%-3,805.61%-6,167.62%-1,633.03%155.76%-202.19%-25,687.20%1.47%-2,321.56%-10,816.97%-2,116.23%
FCF Margin
9.54%-24.60%271.87%-100.59%378.85%-1,036.58%-20.86%-10,701.05%1.18%-2,505.40%-10,020.81%-1,042.27%
Efficiency
Inventory AverageInventory Avg.
0.13M0.24M0.23M0.16M0.15M0.14M0.23M0.27M0.22M0.21M0.21M0.21M0.15M0.05M0.02M0.04M0.04M0.04M0.03M0.02M
Assets AverageAssets Avg.
4.04M4.27M4.47M4.53M4.26M3.89M3.03M2.23M2.04M1.93M1.79M1.61M1.64M1.69M1.59M1.35M1.11M1.00M0.90M0.78M
Equity AverageEquity Avg.
0.75M0.40M0.05M-0.45M-1.01M-0.95M-0.61M-0.70M-0.99M-1.13M-1.47M-1.95M-2.24M-2.73M-3.17M-3.47M-3.75M-2.76M-1.81M-2.13M
Invested CapitalInvested Cap.
Asset Utilization RatioAsset Util.
0.020.100.100.110.100.030.110.120.340.340.280.280.020.000.000.000.000.010.02
Leverage & Solvency
Interest Coverage RatioInterest Cover
-0.04M-0.01M-0.00M-0.00M-0.01M49.41-0.00M-0.03M-0.01M-0.01M-0.02M
Debt Ratio
Times Interest Earned
-0.04M-0.01M-0.00M-0.00M-0.01M49.41-0.00M-0.03M-0.01M-0.01M-0.02M
Valuation
Price to SalesP/S
601.09115.2366.2839.0744.91102.4643.89190.3999.0759.04260.29340.23278.920.00M96.99193.99
Price to BookP/B
265.80
Enterprise Value
59.03M49.59M29.54M17.69M16.53M10.67M10.75M45.53M64.70M35.94M118.56M154.56M7.18M3.71M5.98M8.38M1.19M1.20M2.37M
Market Capitalization
59.09M49.61M29.55M17.73M16.62M10.68M10.78M45.53M64.70M35.94M118.62M154.56M7.19M3.59M5.99M8.39M1.20M1.20M2.40M
Price to FCFP/FCF
0.00M
EV to FCF
0.00M
EV to CFO
903.57664.01
Return Ratios
Return on Sales [ROS]ROS
-351.99%-116.83%-3,805.53%-6,166.88%-1,634.22%155.57%-202.11%-25,683.64%1.50%-2,321.28%-11,737.99%-306.14%-7,487.94%-51,006.31%-2,310.92%-9,184.61%
Return on Capital Employed [ROCE]ROCE
-43.17%-61.44%-91.72%-138.71%-317.43%-185.47%-236.03%
Return on Assets [ROA]ROA
-12.95%-27.44%-34.29%-36.98%-42.16%-43.67%-39.71%-42.25%-40.17%-29.71%-66.93%-80.08%-92.68%-126.91%-124.30%-151.01%-152.48%-137.68%-145.85%-146.51%
Return on Equity [ROE]ROE
-69.95%-295.69%-3,366.50%

Yubo International Biotech Ratios API

Pull Yubo International Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=YBGJ&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY